Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03040102 · ClinicalTrials.gov registry record · NA
Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers
A NA study of Advanced Cancer, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 194
- Enrollment target
- 1
- Study location
NCT03040102: Completed NA study of Advanced Cancer, sponsored by Massachusetts General Hospital.
NCT03040102 is a NA study of Advanced Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 194 participants, below the 245-participant average among 122 other Advanced Cancer trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03040102, a NA study of Advanced Cancer, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 194 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to compare two ways to educate patients with cancer and their caregivers about hospice care services
Primary Outcome
We will ask patients whether they would prefer to receive hospice care at the end of life (yes vs. no)
Conditions Studied
Interventions
- OTHER Standard of Care
- OTHER Hospice Video Educational Tool
Study Locations (1)
Massachusetts
- Massachusetts general Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2017-03-09 |
| Est. Completion | 2019-02-01 |
| Phase | NA |
What the finished NCT03040102 record still lists
NCT03040102 is an interventional study that assigns participants to a tested intervention. The registered 194 participants enrollment target is mid-sized for trials with a published cap, below the 245-participant average among 122 other Advanced Cancer trials with a reported enrollment target (21% lower).
The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT03040102 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03040102 about?
NCT03040102 is a clinical study titled "Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers". The purpose of this research study is to compare two ways to educate patients with cancer and their caregivers about hospice care services
What is the current status of trial NCT03040102?
This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2017-03-09. Estimated completion is 2019-02-01.
What conditions does trial NCT03040102 study?
This clinical trial studies the following conditions: Advanced Cancer.
What interventions are being tested in trial NCT03040102?
The interventions under investigation include: Standard of Care (OTHER), Hospice Video Educational Tool (OTHER).
Who is sponsoring clinical trial NCT03040102?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03040102 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03040102's enrollment target sits among peer trials
194 35th of 122 higher than 88 of 122 other Advanced Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Advanced Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
RECRUITING · NA
-
Pilot Trial of Spiritual Care Interventions for Patients With Cancer
RECRUITING · NA
-
Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services
RECRUITING · NA
-
ALIGN for Older Adults With Cancer in SNFs
RECRUITING · NA
-
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
- NCT05351424 · 194 participants · NA
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI